Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             52 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antisense Oligonucleotides in the Treatment of Non–Small-Cell Lung Cancer Davies, Angela M.
 2003
 S2 p. S68-S73
6 p.
 artikel
2 Bortezomib-Based Combinations in the Treatment of Non–Small-Cell Lung Cancer Davies, Angela M.
 2005
 S2 p. S59-S63
5 p.
 artikel
3 Bortezomib in Lung Cancer Gandara, David R.
 2005
 S2 p. S48-
1 p.
 artikel
4 Bronchoalveolar Carcinoma: Current Treatment and Future Trends Laskin, Janessa J.
 2004
 S2 p. S75-S79
5 p.
 artikel
5 Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer Rosell, Rafael
 2008
 S2 p. S76-S82
7 p.
 artikel
6 Cetuximab as a Single Agent or in Combination with Chemotherapy in Lung Cancer Kim, Edward S.
 2004
 S2 p. S80-S84
5 p.
 artikel
7 Chemotherapy and Antiangiogenic Agents in Non-Small-Cell Lung Cancer Horn, Leora
 2007
 S2 p. S68-S73
6 p.
 artikel
8 Concurrent Chemoradiation Strategies in the Management of Unresectable Stage III non—small-Cell Lung Cancer Lara Jr., Primo N.
 2002
 S2 p. S42-S48
7 p.
 artikel
9 Concurrent Docetaxel and Thoracic Radiation in non—small-Cell Lung Cancer Jänne, Pasi A.
 2002
 S2 p. S37-S41
5 p.
 artikel
10 CT-2103: A Novel Macromolecular Taxane with Potential Advantages Compared with Conventional Taxanes Langer, Corey J.
 2004
 S2 p. S85-S88
4 p.
 artikel
11 Current and Future Strategies for Antiangiogenic Agents in Non–Small-Cell Lung Cancer Herbst, Roy S.
 2008
 S2 p. S50-
1 p.
 artikel
12 Current Data with Pemetrexed in Non–Small-Cell Lung Cancer Adjei, Alex A.
 2003
 S2 p. S64-S67
4 p.
 artikel
13 Current Development of Adjuvant Treatment of Non–Small-Cell Lung Cancer Scagliotti, Giorgio V.
 2004
 S2 p. S63-S70
8 p.
 artikel
14 Current Perspectives with Pemetrexed in Thoracic Malignancies Belani, Chandra P.
 2004
 S2 p. S45-
1 p.
 artikel
15 Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer Fossella, Frank V.
 2002
 S2 p. S23-S28
6 p.
 artikel
16 Docetaxel/Platinum in Advanced non—small-Cell Lung Cancer: Recent Randomized Trials Belani, Chandra P.
 2002
 S2 p. S7-S11
5 p.
 artikel
17 Docetaxel/Radiation Combinations: Rationale and Preclinical Findings Milas, Luka
 2002
 S2 p. S29-S36
8 p.
 artikel
18 Dual Targeting of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor Pathways: Rationale and Clinical Applications for Non-Small-Cell Lung Cancer Byers, Lauren A.
 2007
 S2 p. S79-S85
7 p.
 artikel
19 Emerging Advances in the Management of Lung Cancer Belani, Chandra P.
 2004
 S2 p. S60-
1 p.
 artikel
20 Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer Hirsh, Vera
 2008
 S2 p. S62-S70
9 p.
 artikel
21 Epidermal Growth Factor Receptor Inhibitors plus Chemotherapy in Non–Small-Cell Lung Cancer: Biologic Rationale for Combination Strategies Gandara, David R.
 2007
 S2 p. S61-S67
7 p.
 artikel
22 Gemcitabine and Carboplatin Regimens in Advanced Non–Small-Cell Lung Cancer: Focus on Randomized Phase III Trials Edelman, Martin J.
 2003
 S2 p. S40-S44
5 p.
 artikel
23 Gemcitabine-Based Combinations as Preoperative Therapy in Resectable Non–Small-Cell Lung Cancer Socinski, Mark A.
 2003
 S2 p. S50-S55
6 p.
 artikel
24 Irinotecan and Platinums in the Treatment of Non–Small-Cell Lung Cancer Bunn Jr., Paul A.
 2001
 S2 p. S14-S19
6 p.
 artikel
25 Irinotecan and Taxane Combinations for Non–Small-Cell Lung Cancer Murren, John R.
 2001
 S2 p. S20-S25
6 p.
 artikel
26 Irinotecan (CPT-11) in Triplet Combinations in Patients with Advanced Non–Small-Cell Lung Cancer: A Review and Report of a Phase I/II Trial Socinski, Mark A.
 2001
 S2 p. S26-S33
8 p.
 artikel
27 Irinotecan: Future Directions in Small-Cell Lung Cancer Sandler, Alan
 2001
 S2 p. S9-S13
5 p.
 artikel
28 Irinotecan in Small-Cell Lung Cancer: Current Data Kelly, Karen
 2001
 S2 p. S4-S8
5 p.
 artikel
29 Key Signaling Pathways and Targets in Lung Cancer Therapy Choong, Nicholas W.
 2007
 S2 p. S52-S60
9 p.
 artikel
30 New Agents in the Treatment of Small-Cell Lung Cancer: Focus on Gemcitabine Chiappori, Alberto A.
 2003
 S2 p. S56-S63
8 p.
 artikel
31 Newer Cytotoxic and Targeted Agents Are Advancing the Treatment of Lung Cancer Belani, Chandra P.
 2003
 S2 p. S39-
1 p.
 artikel
32 Novel Combinations Using Pemetrexed in Malignant Mesothelioma Gadgeel, Shirish M.
 2004
 S2 p. S61-S66
6 p.
 artikel
33 Novel Small-Molecule Inhibitors of the Vascular Endothelial Growth Factor Receptor Adjei, Alex A.
 2007
 S2 p. S74-S78
5 p.
 artikel
34 Ongoing Trials with Bevacizumab and Other Antiangiogenic Agents in Lung Cancer Dowlati, Afshin
 2008
 S2 p. S71-S75
5 p.
 artikel
35 Optimizing the Dose and Schedule of Anti–Vascular Endothelial Growth Factor Antibodies in Non–Small-Cell Lung Cancer Klamerus, Justin F.
 2008
 S2 p. S51-S56
6 p.
 artikel
36 Pathogenesis of Malignant Mesothelioma Carbone, Michele
 2004
 S2 p. S46-S50
5 p.
 artikel
37 Pemetrexed Alone and in Combination with Platinum Compounds in the Management of Malignant Mesothelioma Suwanrusme, Harit
 2004
 S2 p. S56-S60
5 p.
 artikel
38 Pemetrexed in the Treatment of Advanced Non–Small-Cell Lung Cancer: A Review of the Clinical Data Zinner, Ralph G.
 2004
 S2 p. S67-S74
8 p.
 artikel
39 Pharmacology and Mechanism of Action of Pemetrexed Adjei, Alex A.
 2004
 S2 p. S51-S55
5 p.
 artikel
40 Preclinical Data with Bortezomib in Lung Cancer Schenkein, David P.
 2005
 S2 p. S49-S55
7 p.
 artikel
41 Proteasome Inhibition in Small-Cell Lung Cancer: Preclinical Rationale and Clinical Applications Lara Jr, Primo N.
 2005
 S2 p. S67-S71
5 p.
 artikel
42 Second-Generation Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Herbst, Roy S.
 2007
 S2 p. S50-S51
2 p.
 artikel
43 Second-Line Chemotherapy for Non–Small-Cell Lung Cancer: Recent Data with Pemetrexed Hanna, Nasser H.
 2004
 S2 p. S75-S79
5 p.
 artikel
44 Sequencing Bortezomib with Chemotherapy and Targeted Agents Adjei, Alex A.
 2005
 S2 p. S56-S58
3 p.
 artikel
45 The Emerging Role of Gemcitabine in Combination with Radiation in Locally Advanced, Unresectable Non–Small-Cell Lung Cancer Langer, Corey J.
 2003
 S2 p. S45-S49
5 p.
 artikel
46 The Potential Role of Bortezomib in Combination with Chemotherapy and Radiation in Non–Small-Cell Lung Cancer Edelman, Martin J.
 2005
 S2 p. S64-S66
3 p.
 artikel
47 The Role of Docetaxel in Nonplatinum-Based Combination Chemotherapy for non—small-Cell Lung Cancer Petty, W. Jeffrey
 2002
 S2 p. S12-S16
5 p.
 artikel
48 The Role of Weekly Docetaxel in the Treatment of Advanced non—small-Cell Lung Cancer Hainsworth, John D.
 2002
 S2 p. S17-S22
6 p.
 artikel
49 Topoisomerase I Inhibitors in the Combined Modality Therapy of Lung Cancer Choy, Hak
 2001
 S2 p. S34-S40
7 p.
 artikel
50 Treatment of Patients Excluded from Eastern Cooperative Oncology Group 4599 and AVAiL Studies: Focus on Brain Metastasis and Squamous Histology Morgensztern, Daniel
 2008
 S2 p. S57-S61
5 p.
 artikel
51 Treatment of Patients with Advanced Lung Cancer and Poor Performance Status Lilenbaum, Rogerio C.
 2004
 S2 p. S71-S74
4 p.
 artikel
52 Use of Proteasome Inhibition in the Treatment of Lung Cancer Schenkein, David P.
 2004
 S2 p. S89-S96
8 p.
 artikel
                             52 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland